Cargando…

The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines

BACKGROUND: Venous thromboembolism (VTE) is a common complication among patients with cancer and is one of the most common causes of increased morbidity and mortality. The use of direct oral anticoagulants (DOACs) for thromboprophylaxis and treatment of cancer-associated venous thromboembolism (CA-V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsubaie, Norah S., Al Rammah, Shahad M., Alshouimi, Reema A., Alzahrani, Mohammed Y., Al Yami, Majed S., Almutairi, Abdulaali R., Alfayez, Osamah M., Korayem, Ghazwa B., Almohammed, Omar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556878/ https://www.ncbi.nlm.nih.gov/pubmed/34717653 http://dx.doi.org/10.1186/s12959-021-00326-2

Ejemplares similares

Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center
por: Korayem, Ghazwa B., et al.
Publicado: (2021)

Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
por: Altoukhi, Renad M, et al.
Publicado: (2020)

Real-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia
por: Al Yami, Majed S, et al.
Publicado: (2021)

Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis
por: Alfayez, Osamah M., et al.
Publicado: (2020)

Clinical characteristics and dosing of apixaban and rivaroxaban for the management of venous thromboembolism: A multi-center retrospective observational study
por: Al Yami, Majed S., et al.
Publicado: (2023)

Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies
por: Alfayez, Osamah M., et al.
Publicado: (2022)

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective
por: Alkhatib, Nimer S., et al.
Publicado: (2022)

Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment
por: Al Yami, Majed S, et al.
Publicado: (2018)

Parents' Hesitancy to Vaccinate Their 5–11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model
por: Almalki, Ohoud S., et al.
Publicado: (2022)

Corrigendum: Parents' Hesitancy to Vaccinate Their 5–11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model
por: Almalki, Ohoud S., et al.
Publicado: (2022)

Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study
por: Korayem, Ghazwa B, et al.
Publicado: (2023)

Impact of Thromboprophylaxis Intensity on Patients’ Mortality Among Hospitalized Patients with COVID-19: A Propensity-Score Matched Study
por: Almohareb, Sumaya N, et al.
Publicado: (2022)

The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia
por: Alfayez, Osamah M., et al.
Publicado: (2022)

Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies
por: Alshehri, Abdulmajeed M., et al.
Publicado: (2022)

The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study
por: Korayem, Ghazwa B., et al.
Publicado: (2022)

The impact of pharmacists providing direct patient care as members of interprofessional teams on diabetes management
por: Alfayez, Osamah M., et al.
Publicado: (2017)

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
por: Minet, Clémence, et al.
Publicado: (2015)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
por: Willems, R. A. L., et al.
Publicado: (2023)

Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia
por: Al-Hameed, Fahad M., et al.
Publicado: (2017)

Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2013)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Efficacy, Safety, and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury: A Systematic Review
por: Arnold, Paul M., et al.
Publicado: (2017)

Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study
por: Alshaya, Omar A., et al.
Publicado: (2022)

Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis – A Retrospective Study
por: Ambra, Naseem, et al.
Publicado: (2022)

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
por: Aryal, Madan Raj, et al.
Publicado: (2020)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Hafiz, Awatif, et al.
Publicado: (2023)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery
por: Gao, Yuan, et al.
Publicado: (2016)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study
por: Almodaimegh, Hind, et al.
Publicado: (2017)

Analysis of Adherence to Thromboprophylaxis and Incidence of Venous Thromboembolism After Lower Limb Orthopaedic Surgery
por: Benjamin, Miles W, et al.
Publicado: (2021)

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
por: Rajabi, Fereshteh, et al.
Publicado: (2012)

Knowledge of thromboprophylaxis guidelines pre- and post-didactic lectures during a venous thromboembolism awareness day at a tertiary-care hospital
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013)

Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study
por: Aljuhani, Ohoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5qmcfvek6l4al0kpvvs4v5fsg5